Authors: Hezard, N Metz, D Tassan-Mangina, S Potron, G Nguyen, P

Citation: N. Hezard et al., Unexpected flow cytometric results with two small GPIIb/IIIa blockers: Eptifibatide and tirofiban, THROMB HAEM, 85(3), 2001, pp. 561-562

Authors: Hezard, N Metz, D Garnotel, R Droulle, C Potron, G Nguyen, P

Citation: N. Hezard et al., Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation., J MAL VASC, 25(5), 2000, pp. 343-348

Authors: Hezard, N Metz, D Nazeyrollas, P Droulle, C Elaerts, J Potron, G Nguyen, P

Citation: N. Hezard et al., Use ct the PFA-100 (TM) apparatus to assess platelet function in patients undergoing PTCA during and after infusion of cE3 Fab in the presence of other antiplatelet agents, THROMB HAEM, 83(4), 2000, pp. 540-544

Authors: Nguyen, P Broussas, M Bertin, E Simon, G Hezard, N Potron, G

Citation: P. Nguyen et al., Measurement of monocyte activation: application in the investigation of diabetic patients., J MAL VASC, 24(4), 1999, pp. 275-280

Authors: Hezard, N Metz, D Simon, G Droulle, C Daliphard, S Potron, G

Citation: N. Hezard et al., Platelet activation in coronary heart disease: assay, application and therapeutical perspectives, J MAL VASC, 24(4), 1999, pp. 288-293

Authors: Hezard, N Metz, D Nazeyrollas, P Nguyen, P Simon, G Daliphard, S Droulle, C Elaerts, J Potron, G

Citation: N. Hezard et al., Free and total platelet glycoprotein IIb IIIa measurement in whole blood by quantitative flow cytometry during and after infusion of c7E3 Fab in patients undergoing PTCA, THROMB HAEM, 81(6), 1999, pp. 869-873